Artificial Intelligence will soon be common place in radiology workflows. At this year’s Radiological Society of North American (RSNA) annual meeting, AI was the focal point of many sessions and various med-tech companies were excited to show off their latest AI integrations and innovations.
EnvoyAI, a catalog of AI algorithms, and Arterys, a cloud-based medical imaging platform, were two of the companies that demonstrated their AI-based offerings at the event.
EnvoyAI already has 14 partner contracts and three Food and Drug Administration (FDA) approved algorithms that can be purchased on its Exchange. In total, they have 35 algorithms on the Exchange that can be integrated into hospital workflows, and they’re are anticipating 510(k) clearances in the next six to 12 months.
"Our platform enables physicians to interact with AI in their native workflow, keeping doctors in control and empowering them to take AI input into account, but on their own terms,” said Misha Herscu, EnvoyAI’s CEO.
Arterys is closing out the year with a few successful milestones. As of January 2017, the Arterys Cardio DL became the first cloud computing software for healthcare systems to receive 510(k) clearance, allowing the platform to be integrated into cardiac flow quantification, such as 4D Flow and 2D Phase Contrast workflows. The technology showcased the 4d Flow software during the RSNA poster sessions.
The San Francisco-based company also received $30 million in Series B funding in November, with Temasek as the leading investor and NewYork-Presbyterian, Emergent Medical Partners, Northwell Health Ventures, Varian Medical Systems, GE Ventures, Fosun, DNA Capital, and ORI Capital as participating investors.+